Tamar Grossman

Tamar Grossman is from San Diego, California, United States. Tamar is currently Co-Founder & Chief Executive Officer at La Jolla Labs Inc., located in San Diego, California, United States. Tamar also works as Board Member at 1STRAND, a job Tamar has held since Jan 2024. Another title Tamar currently holds is Co-Founder, Board member at La Jolla Labs Inc.. In Tamar's previous role as a Vice President, Global head of RNA, Gene Therapy and Delivery at Johnson & Johnson Innovative Medicine, Tamar worked in United States until Dec 2024. Prior to joining Johnson & Johnson Innovative Medicine, Tamar was a Vice President, Global head of RNA and Targeted Therapeutics at Johnson & Johnson Innovative Medicine and held the position of Vice President, Global head of RNA and Targeted Therapeutics at South San Francisco, California, United States. Prior to that, Tamar was a Global Head of RNA and Targeted Therapeutics at Johnson & Johnson Innovative Medicine from Aug 2021 to Apr 2022. Tamar started working as Senior Director, Head of Rare Diseases at Arcturus Therapeutics in Mar 2020. From Jul 2018 to Mar 2020, Tamar was Director, Translational Medicine at Ionis Pharmaceuticals, Inc.. Prior to that, Tamar was a Director, Functional Genomics, Antisense Drug Discovery at Ionis Pharmaceuticals, Inc., based in Greater San Diego Area from Aug 2017 to Mar 2020. Tamar started working as Associate Director, Functional Genomics, Antisense Drug Discovery at Ionis Pharmaceuticals in Sep 2013.